World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

Login Register
World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

SJIF Impact Factor: 6.842

Abstract

HCV SEROCONVERSIONS IN DIALYSIS PATIENTS – A STUDY FROM SOUTH INDIA

Dr. Devidas Bantewad* and Dr. Manjusha Yadla

ABSTRACT

Hepatitis C virus (HCV) infection is common and associated with significant morbidity and mortality among dialysis patients. HCV infection is more common in dialysis patients than in healthy populations. The prevalence of hepatitis C (HCV) infection among the patients on hemodialysis (HD) varies from country to country and from one center to another in the same country. Global prevalence of HCV is 2.5%. The prevalence of HCV in MHD patients ranges from 6–60% whereas in India various studies show a prevalence of 4.3% to 45%.[1] This study aimed to evaluate the seroconversion rate of hepatitis C infection.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR